New Tool Can Help Improve Health Equity in Cancer Centers : Oncology Times
An abstract is unavailable.
Related Articles
A Pragmatist’s View on Biomarker-Driven Decisions in Oncology: Episode 1
Website: https://www.onclive.comTwitter: https://twitter.com/OncLiveFacebook: https://www.facebook.com/OncLive/LinkedIn: https://www.linkedin.com/company/onc…
A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer
Acha-Sagredo et al. stratify colorectal cancers using features of an immune-reactive tumor microenvironment. This microenvironment, locally abundant in cytotoxic lymphocytes and antigen-presenting macrophages, facilitates immunotherapy response…
Revisit Every OncLive On Air Episode From December 2024
In case you missed any, read a recap of the episodes of OncLive On Air that aired in December 2024.
Genetic counseling comes to CH Hospital – The Chestnut Hill Local
Fox Chase Cancer Center has expanded its genetic counseling and high-risk breast cancer services to Temple Health – Chestnut Hill Hospital.
Blood Podcast | Blood | American Society of Hematology
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly…
NCCN publishes patient resource on genetic testing to guide patient decisionmaking – The Cancer Letter
The National Comprehensive Cancer Network published its first patient resource aimed at informing people about the latest recommendations around hereditary and familial cancer risk. The…
Cedars-Sinai Cancer’s model of care ensured patient care amid wildfires – The Cancer Letter
Over the past five years, Cedars-Sinai Cancer has built an integrated, regional system designed to provide cancer care close to where patients live and work.…
Understanding Graft-VS-Host Disease (GVHD) Basics
Panelists discuss how graft-vs-host disease (GVHD) is a complex immune-mediated condition, highlighting the differences between acute and chronic GVHD, the associated risk factors, prognosis, and…